Home → Financial Coverage
Expanding financial coverage through insurance
Expanding financial coverage through insurance
Cutting-edge cancer treatments — particularly in the field of immuno-oncology (IO) — are delivering a lifeline to patients. But, as new therapies become available, even the best-resourced healthcare systems need to take decisions about how to provide access. The challenge is particularly acute in developing economies.
In many cases, private health insurers are already making an impact through the development of new funding models. So, what are the lessons from innovative insurance programmes around the world that are increasing access to IO therapies?
If you want to know more about our solutions, don't hesitate to contact us by clicking on the e-mail address
If you want to know more about our solutions, don't hesitate to contact us by clicking on the e-mail address
Copyright 2022 Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, N.J., U.S.A., All rights reserved.
Copyright 2022 Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, N.J., U.S.A., All rights reserved.